clarithromycin is primarily used to treat a number of bacterial infections including pneumonia , helicobacter pylori , and as an alternative to penicillin in strep throat it is effective against upper and lower respiratory tract infections , skin and soft tissue infections and helicobacter pylori infections associated with duodenal ulcers clarithromycin should not be used in the setting of hypokalaemia ( low blood potassium ) use of clarithromycin with the following medications : cisapride , pimozide , astemizole , terfenadine , ergotamine , ticagrelor , ranolazine or dihydroergotamine is not recommended hypersensitivity to clarithromycin or any component of the product , erythromycin , or any macrolide antibiotics in patients with long qt syndrome , cardiac disease , or patients taking other qt-prolonging medications , this can increase risk for life-threatening arrhythmias clarithromycin has been known to cause jaundice , cirrhosis , and kidney problems , including kidney failure a risk of oral candidiasis and vaginal candidiasis , due to the elimination of the yeast natural bacterial competitors by the antibiotic , has also been noted clarithromycin can cause potential hazard to the fetus hence should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus taking clarithromycin with other medications that are metabolized by cyp3a4 may lead to unexpected increases or decreases in drug levels combining these two drugs may lead to fatal colchicine toxicity , particularly in people with chronic kidney disease for example , clarithromycin may lead to decreased zidovudine concentrations during active phagocytosis , large concentrations of clarithromycin are released ; its concentration in the tissues can be over 10 times higher than in plasma image : clarith-200.jpg thumb 150px a pack of clarithromycin tablets manufactured by taisho pharmaceutical 